Keros Therapeutics
KROS
KROS
103 hedge funds and large institutions have $433M invested in Keros Therapeutics in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 43 increasing their positions, 20 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
52% less capital invested
Capital invested by funds: $893M → $433M (-$460M)
100% less funds holding in top 10
Funds holding in top 10: 5 → 0 (-5)
Holders
103
Holding in Top 10
–
Calls
$1.84M
Puts
–
Top Buyers
| 1 | +$16.4M | |
| 2 | +$12.6M | |
| 3 | +$8.49M | |
| 4 |
Alkeon Capital Management
New York
|
+$7.46M |
| 5 |
Renaissance Technologies
New York
|
+$3.77M |
Top Sellers
| 1 | -$17.7M | |
| 2 | -$14M | |
| 3 | -$5.19M | |
| 4 |
KHLMVGHM
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet
Tel Aviv,
Israel
|
-$5.16M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
-$4.41M |